Review



murine skin fibroblasts l929 cell line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC murine skin fibroblasts l929 cell line
    Dependence of proliferation modulation activity (expressed as 3 H-thymidine incorporation, in percentage ( y -axis) of the respective, untreated control) on chemical structure and concentration of eleven DHP compounds on <t>L929</t> cells.
    Murine Skin Fibroblasts L929 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 3252 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine skin fibroblasts l929 cell line/product/ATCC
    Average 99 stars, based on 3252 article reviews
    murine skin fibroblasts l929 cell line - by Bioz Stars, 2026-02
    99/100 stars

    Images

    1) Product Images from "Dihydropyridine Derivatives as Cell Growth Modulators In Vitro"

    Article Title: Dihydropyridine Derivatives as Cell Growth Modulators In Vitro

    Journal: Oxidative Medicine and Cellular Longevity

    doi: 10.1155/2017/4069839

    Dependence of proliferation modulation activity (expressed as 3 H-thymidine incorporation, in percentage ( y -axis) of the respective, untreated control) on chemical structure and concentration of eleven DHP compounds on L929 cells.
    Figure Legend Snippet: Dependence of proliferation modulation activity (expressed as 3 H-thymidine incorporation, in percentage ( y -axis) of the respective, untreated control) on chemical structure and concentration of eleven DHP compounds on L929 cells.

    Techniques Used: Activity Assay, Control, Concentration Assay

    (a) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on L929 cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). Control cells (Ctrl) without DOXO (0 μ g/mL) are presented in the 1st bar of each column. First column (0): control cells treated with DOXO, without DHPs. Added DOXO concentrations were expressed as μ g/mL: 0.1 μ g/mL, 0.5 μ g/mL, and 1 μ g/mL. Results were expressed as mean values of counts per minute (CPM) ± SD. (b) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HMEC cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). (c) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HOS cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). (d) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HeLa cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis).
    Figure Legend Snippet: (a) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on L929 cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). Control cells (Ctrl) without DOXO (0 μ g/mL) are presented in the 1st bar of each column. First column (0): control cells treated with DOXO, without DHPs. Added DOXO concentrations were expressed as μ g/mL: 0.1 μ g/mL, 0.5 μ g/mL, and 1 μ g/mL. Results were expressed as mean values of counts per minute (CPM) ± SD. (b) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HMEC cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). (c) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HOS cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). (d) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HeLa cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis).

    Techniques Used: Activity Assay, Control



    Similar Products

    murine skin fibroblasts l929 cell line  (ATCC)
    99
    ATCC murine skin fibroblasts l929 cell line
    Dependence of proliferation modulation activity (expressed as 3 H-thymidine incorporation, in percentage ( y -axis) of the respective, untreated control) on chemical structure and concentration of eleven DHP compounds on <t>L929</t> cells.
    Murine Skin Fibroblasts L929 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine skin fibroblasts l929 cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    murine skin fibroblasts l929 cell line - by Bioz Stars, 2026-02
    99/100 stars
    		  Buy from Supplier
    murine skin fibroblast cell line l929  (DS Pharma Biomedical)
    90
    DS Pharma Biomedical murine skin fibroblast cell line l929
    Dependence of proliferation modulation activity (expressed as 3 H-thymidine incorporation, in percentage ( y -axis) of the respective, untreated control) on chemical structure and concentration of eleven DHP compounds on <t>L929</t> cells.
    Murine Skin Fibroblast Cell Line L929, supplied by DS Pharma Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine skin fibroblast cell line l929/product/DS Pharma Biomedical
    Average 90 stars, based on 1 article reviews
    murine skin fibroblast cell line l929 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Dependence of proliferation modulation activity (expressed as 3 H-thymidine incorporation, in percentage ( y -axis) of the respective, untreated control) on chemical structure and concentration of eleven DHP compounds on L929 cells.

    Journal: Oxidative Medicine and Cellular Longevity

    Article Title: Dihydropyridine Derivatives as Cell Growth Modulators In Vitro

    doi: 10.1155/2017/4069839

    Figure Lengend Snippet: Dependence of proliferation modulation activity (expressed as 3 H-thymidine incorporation, in percentage ( y -axis) of the respective, untreated control) on chemical structure and concentration of eleven DHP compounds on L929 cells.

    Article Snippet: To test the effects of DHPs on the growth of different types of cells in vitro we used the 3 H-thymidine incorporation assay reflecting the DNA synthesis (i.e., the cell growth) of murine skin fibroblasts L929 cell line (NCTC clone 929 [L cell, L-929, derivative of Strain L] (ATCC CCL-1TM)), human endothelial cells HMEC-1 (ATCC CRL-3243TM), human cervical carcinoma HeLa (ATCC CCL-2TM), and human osteosarcoma cell line HOS (ATCC CRL-1543TM), which in vitro grows resembling osteoblast cells.

    Techniques: Activity Assay, Control, Concentration Assay

    (a) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on L929 cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). Control cells (Ctrl) without DOXO (0 μ g/mL) are presented in the 1st bar of each column. First column (0): control cells treated with DOXO, without DHPs. Added DOXO concentrations were expressed as μ g/mL: 0.1 μ g/mL, 0.5 μ g/mL, and 1 μ g/mL. Results were expressed as mean values of counts per minute (CPM) ± SD. (b) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HMEC cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). (c) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HOS cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). (d) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HeLa cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis).

    Journal: Oxidative Medicine and Cellular Longevity

    Article Title: Dihydropyridine Derivatives as Cell Growth Modulators In Vitro

    doi: 10.1155/2017/4069839

    Figure Lengend Snippet: (a) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on L929 cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). Control cells (Ctrl) without DOXO (0 μ g/mL) are presented in the 1st bar of each column. First column (0): control cells treated with DOXO, without DHPs. Added DOXO concentrations were expressed as μ g/mL: 0.1 μ g/mL, 0.5 μ g/mL, and 1 μ g/mL. Results were expressed as mean values of counts per minute (CPM) ± SD. (b) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HMEC cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). (c) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HOS cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis). (d) Proliferation modulation activity of DOXO (columns 0) and of DHP derivatives K-2-11 and IB-32 (10 μ g/mL) alone and in the presence of DOXO on HeLa cells (expressed as 3 H-thymidine incorporation, in CPM, y -axis).

    Article Snippet: To test the effects of DHPs on the growth of different types of cells in vitro we used the 3 H-thymidine incorporation assay reflecting the DNA synthesis (i.e., the cell growth) of murine skin fibroblasts L929 cell line (NCTC clone 929 [L cell, L-929, derivative of Strain L] (ATCC CCL-1TM)), human endothelial cells HMEC-1 (ATCC CRL-3243TM), human cervical carcinoma HeLa (ATCC CCL-2TM), and human osteosarcoma cell line HOS (ATCC CRL-1543TM), which in vitro grows resembling osteoblast cells.

    Techniques: Activity Assay, Control